Insiders · Profile

Emmens Matthew

Director at Vertex Pharmaceuticals. Filing since 6 Feb 2011. CIK 0001298332

Company

Date

Role

Action

Amount

Of holding

16 Nov 2012

Director

Sold, plan not stated

10,850

$453.10K

5.1%

25 May 2011

CEO & President

Sold, plan not stated

9,735

$540.39K

4.2%

6 Feb 2011

Executive Chairman

Sold, plan not stated

56,000

$2.12M

20.9%

3 decisions on file.